Skip to content

EyePoint, Inc. EYPT Increase (Decrease) in Inventories

Increase (Decrease) in Inventories at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+189%
Enterprise value$1.15B+228%
P/S158.5×+151×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's increase (decrease) in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's increase (decrease) in inventories?
EyePoint, Inc. (EYPT) reported increase (decrease) in inventories of -$563K in Q1 2026.
How has EyePoint, Inc. 's increase (decrease) in inventories changed year-over-year?
EyePoint, Inc. 's increase (decrease) in inventories decreased by 357.7% year-over-year, from -$123K to -$563K.
What is the long-term trend for EyePoint, Inc. 's increase (decrease) in inventories?
Over 4 years (2021 to 2025), EyePoint, Inc. 's increase (decrease) in inventories has grown at a -22.3% compound annual growth rate (CAGR), from -$1.35M to -$492K.
What does increase (decrease) in inventories mean?
This metric measures the net change in the value of raw materials, work-in-progress, and finished goods held by the company. It provides insight into supply chain efficiency, inventory management effectiveness, and potential shifts in production demand.